Skip to content
2000
Volume 25, Issue 4
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

A mystery pathogen that has not yet infected the entire world’s population is predicted to be the cause of Disease X, which will be contagious. According to WHO scientists, 50 million people are expected to die from Disease X, which would be 20 times deadlier than coronavirus disease 2019 (COVID-19). Many international initiatives are currently in motion to get ready for future pandemics. These include updating the International Health Regulation and the European Legislation, establishing the Health Emergency Preparedness and Response Authority (HERA), establishing international hubs, taking on the international challenge of developing a vaccine for Disease X within 100 days of recognition of emerging Pathogen X, and updating the preparedness plan of National Institute of Allergy and Infectious Diseases. Our current review’s main objective is to determine whether black seeds () can manage Disease X. It has been established by several studies that black seeds () have antiviral, antibacterial, antimicrobial, immunomodulatory, anti-inflammatory, and antioxidant properties, which would be useful in the management of Disease X. Black seeds () may be utilized in conjunction with supportive care and symptomatic therapy to manage Disease X in early phases. Future randomized controlled clinical trials would further evaluate the safety and effectiveness of black seeds () in patients with Disease X.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265304758240821113606
2024-09-20
2025-09-01

  • From This Site

    /content/journals/iddt/10.2174/0118715265304758240821113606
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BurkiT. Known unknowns and unknown unknowns.Lancet Infect. Dis.201818438538610.1016/S1473‑3099(18)30181‑6 29582769
     [Google Scholar]
  2. HonigsbaumM. Disease X and other unknowns.Lancet2019393101801496149710.1016/S0140‑6736(19)30803‑7 30983581
     [Google Scholar]
  3. ThakurN. PatelK.A. HallI. DuggalY.N. CuiS. A dataset of search interests related to disease x originating from different geographic regions.Preprints202310.20944/preprints202308.1701.v1
     [Google Scholar]
  4. World Health OrganizationWho to identify pathogens that could cause future outbreaks and pandemics.2022Available From: https://www.who.int/news/item/21-11-2022-who-to-identify-pathogens-that-could-cause-future-outbreaks-and-pandemics
    [Google Scholar]
  5. TahirM.J. SawalI. EssarM.Y. Disease X: A hidden but inevitable creeping danger.Infect. Control Hosp. Epidemiol.202243111758175910.1017/ice.2021.342 34308811
     [Google Scholar]
  6. SiddiquiA. AdnanA. Transcriptomics and the hunt for Disease X; A view point from Ebola and COVID-19 outbreaks.Ann. Med. Surg. (Lond.)20228110455210.1016/j.amsu.2022.104552 36091195
     [Google Scholar]
  7. BanerjeeS. SultanaQ. MukherjeeD. AgrawalV. JaiswalV. PaudelK. Disease‐X: Accounting for the unknown.Health Sci. Rep.202364e117310.1002/hsr2.1173 37008815
     [Google Scholar]
  8. ChatterjeeP. NairP. ChersichM. One Health,“Disease X” & the challenge of “unknown” unknowns.Indian J. Med. Res.2021153326427110.4103/ijmr.IJMR_601_21 33906988
     [Google Scholar]
  9. PossasC. MarquesE.T.A. RisiJ.B.Jr HommaA. COVID-19 and future disease X in circular economy transition: Redesigning pandemic preparedness to prevent a global disaster.Circ. Eco. Sustainabil2021141463147810.1007/s43615‑021‑00060‑x 34888566
     [Google Scholar]
  10. SinhaS. BhattacharyaS. TilakV.W. SinhaS. DiseaseX. DiseaseX. Exploring the Unexplored, Knowable Unknown.J. Commun. Dis.202153413513910.24321/0019.5138.202183
     [Google Scholar]
  11. SimpsonS. KaufmannM.C. GlozmanV. ChakrabartiA. DiseaseX. Accelerating the development of medical countermeasures for the next pandemic.Lancet Infect. Dis.2020205e108e11510.1016/S1473‑3099(20)30123‑7 32197097
     [Google Scholar]
  12. SimpsonS. ChakrabartiA. RobinsonD. ChirgwinK. LumpkinM. Navigating facilitated regulatory pathways during a disease X pandemic. npj.Vaccines (Basel)202051101 32102455
     [Google Scholar]
  13. MipatriniD. MontaldoC. BartoliniB. ‘Disease X’—time to act now and prepare for the next pandemic threat.Eur. J. Public Health202232684184210.1093/eurpub/ckac151 36250806
     [Google Scholar]
  14. MaideenN.M.P. Potential of black seeds (Nigella Sativa) in the management of COVID-19 among children.IJMDAT20214e366
     [Google Scholar]
  15. MaideenN.M. RajkapoorB. SudhaM. MirunaliniG. MohamedR. Therapeutic potentials of black seeds (Nigella Sativa) in the management of COVOD-19-a review of clinical and studies.Antiinfect. Agents202220e020822207222
     [Google Scholar]
  16. Pakkir MaideenN.M. Hassan JumaleA. Ramadan BarakatI. Khalifa AlbastiA. Potential of Black Seeds (Nigella Sativa) in the Management of Long COVID or Post-acute Sequelae of COVID-19 (PASC) and Persistent COVID-19 Symptoms - An Insight.Infect. Disord. Drug Targets2023234e230223213955
     [Google Scholar]
  17. MaideenN.M. HaddaT.B. AlmalkiF.A. MoueqquitM. KawsarS.M. Black Seeds (Nigella Sativa) for the Management of COVID-19 in Pregnant and Breastfeeding Women: An Insight.J Complem Alternat Med Res20232321426
     [Google Scholar]
  18. MaideenN.M.P. A review of inherent beneficial effects of black seeds (Nigella Sativa) in marburg virus disease management.Food and Health202352610.53388/FH2023006
     [Google Scholar]
  19. MohamedN. Probable beneficial effects of black seeds (Nigella Sativa) in the management of langya henipavirus infection.Food and Health2022441710.53388/FH20221101017
     [Google Scholar]
  20. ArmitageR. NellumsL.B. DiseaseX. Availability bias, biotechnology and seeing beyond zoonotic risk.Public Health2021190e2510.1016/j.puhe.2020.11.012 33349433
     [Google Scholar]
  21. IskraE. PachniaA. DropB. Polz-DacewiczM. The disease X: Waiting for the next pandemic.Zdrow. Publiczne20221321313310.2478/pjph‑2022‑0006
     [Google Scholar]
  22. MaideenN.M.P. Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19?J. Pharmacopuncture2020232627010.3831/KPI.2020.23.010 32685234
     [Google Scholar]
  23. ÖzçakmakS. AlMatarM. VarI. TekinA. Investigation on the Microbiological Quality and Fatty Acid Methyl Esters Composition of Commercially Available Cold-pressed Nigella Sativa L. Oil.Curr. Anal. Chem.202319756156910.2174/0115734110265562230927091336
     [Google Scholar]
  24. ForouzanfarF. BazzazB.S. HosseinzadehH. Black cumin (Nigella Sativa) and its constituent (thymoquinone): A review on antimicrobial effects.Iran. J. Basic Med. Sci.20141712929938 25859296
     [Google Scholar]
  25. HanafyM.S.M. HatemM.E. Studies on the antimicrobial activity of Nigella Sativa seed (black cumin).J. Ethnopharmacol.1991342-327527810.1016/0378‑8741(91)90047‑H 1795532
     [Google Scholar]
  26. ShafodinoF.S. LusilaoJ.M. MwapaghaL.M. Phytochemical characterization and antimicrobial activity of Nigella Sativa seeds.PLoS One2022178e027245710.1371/journal.pone.0272457 35926002
     [Google Scholar]
  27. MaideenN.M. Miracle Herb to Cure HIV-Black Seeds (Nigella Sativa): A Review.Int J Med Rev202183116121
     [Google Scholar]
  28. Al-GhamdiS.S. Nigella Sativa seeds protect from viral hepatitis B virus infection.Curr. Top. Pharmacol.2008122101104
     [Google Scholar]
  29. BarakatE.M.F. El WakeelL.M. HagagR.S. Effects of Nigella Sativa on outcome of hepatitis C in Egypt.World J. Gastroenterol.201319162529253610.3748/wjg.v19.i16.2529 23674855
     [Google Scholar]
  30. Abdel-MoneimA. MorsyB.M. MahmoudA.M. Abo-SeifM.A. ZanatyM.I. Beneficial therapeutic effects of Nigella Sativa and/or Zingiber officinale in HCV patients in Egypt.EXCLI J.201312943955 27298610
     [Google Scholar]
  31. MaideenN.M. HaddaT.B. AlmalkiF.A. LaarousiH. SolimanS.S. KawsarS. Black seeds (Nigella Sativa) for the management of dengue viral disease: Insight into the evidence and POM analyses for the identification of antiviral pharmacophore sites: A review.Journal of Medicinal Herbs20231411936
     [Google Scholar]
  32. ShoaibA. JavedS. WahabS. Cellular, molecular, pharmacological, and nano-formulation aspects of thymoquinone—a potent natural antiviral agent.Molecules20232814543510.3390/molecules28145435 37513307
     [Google Scholar]
  33. Ciesielska-FiglonK. WojciechowiczK. WardowskaA. LisowskaK.A. The Immunomodulatory Effect of Nigella Sativa.Antioxidants2023127134010.3390/antiox12071340 37507880
     [Google Scholar]
  34. KavyaniZ. MusazadehV. Golpour-hamedaniS. MoridpourA.H. VajdiM. AskariG. The effect of Nigella Sativa (black seed) on biomarkers of inflammation and oxidative stress: An updated systematic review and meta-analysis of randomized controlled trials.Inflammopharmacology20233131149116510.1007/s10787‑023‑01213‑0 37036558
     [Google Scholar]
  35. HallajzadehJ. MilajerdiA. MobiniM. Effects ofNIGELLA SATIVA on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta‐analysis of randomized controlled clinical trials.Phytother. Res.202034102586260810.1002/ptr.6708 32394508
     [Google Scholar]
  36. SaadatiS. NaseriK. AsbaghiO. Nigella Sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Front. Nutr.2022997775610.3389/fnut.2022.977756 36034891
     [Google Scholar]
  37. MontazeriR.S. FatahiS. SohouliM.H. The effect of Nigella Sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomized controlled trials.J. Food Biochem.2021454e1362510.1111/jfbc.13625 33559935
     [Google Scholar]
  38. MalekianS. Ghassab-AbdollahiN. MirghafourvandM. Farshbaf-KhaliliA. The effect of Nigella Sativa on oxidative stress and inflammatory biomarkers: A systematic review and meta-analysis.J. Complement. Integr. Med.202118223525910.1515/jcim‑2019‑0198 34187123
     [Google Scholar]
  39. TangG. ZhangL. TaoJ. WeiZ. Effect of Nigella Sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized controlled trials.Phytother. Res.20213584183419310.1002/ptr.7080 33728708
     [Google Scholar]
  40. MohitM. FarrokhzadA. FarajiS.N. Heidarzadeh-EsfahaniN. KafeshaniM. Effect of Nigella Sativa L. supplementation on inflammatory and oxidative stress indicators: A systematic review and meta-analysis of controlled clinical trials.Complement. Ther. Med.20205410253510.1016/j.ctim.2020.102535 33183658
     [Google Scholar]
  41. TavakolyR. ArabA. VallianouN. The effect of Nigella Sativa L. supplementation on serum C-reactive protein: A systematic review and meta‐analysis of randomized controlled trials.Complement. Ther. Med.20194514915510.1016/j.ctim.2019.06.008 31331553
     [Google Scholar]
  42. HanA. ShiD. The efficacy of Nigella Sativa supplementation for asthma control: A meta-analysis of randomized controlled studies.Postepy Dermatol. Alergol.202138456156510.5114/ada.2020.93220
     [Google Scholar]
  43. RashwanH.K. MahgoubS. AbuelezzN.Z. AminH.K. Black cumin seed (Nigella Sativa) in inflammatory disorders: Therapeutic potential and promising molecular mechanisms.Drugs Drug Candid20232251653710.3390/ddc2020027
     [Google Scholar]
  44. ArdianaM. PikirB.S. SantosoA. HermawanH.O. Al-FarabiM.J. Effect of Nigella Sativa supplementation on oxidative stress and antioxidant parameters: A meta-analysis of randomized controlled trials.ScientificWorldJournal202020201710.1155/2020/2390706 32454800
     [Google Scholar]
  45. MaideenN.M.P. Nigella Sativa (Black seeds) – Potential Herb to Help Weight Loss.Curr. Tradit. Med.202284e09112119783310.2174/2215083807666211109115834
     [Google Scholar]
  46. MaideenN.M.P. Antidiabetic activity of Nigella Sativa (black seeds) and its active constituent (Thymoquinone): A review of human and experimental animal studies.Chonnam Med. J.202157316917510.4068/cmj.2021.57.3.169 34621636
     [Google Scholar]
  47. MaideenN.M.P. BalasubramanianR. RamanathanS. Nigella Sativa (Black Seeds), A Potential Herb for the Pharmacotherapeutic Management of Hypertension - A Review.Curr. Cardiol. Rev.2021174e23042118778610.2174/1573403X16666201110125906 33172379
     [Google Scholar]
  48. MaideenN.M.P. Effects of Nigella Sativa (Black seeds) Supplementation on Plasma Lipid Profile in Human Subjects - A Review.Current Nutraceuticals202231e02122119848710.2174/2665978602666211202102631
     [Google Scholar]
/content/journals/iddt/10.2174/0118715265304758240821113606
Loading
An Overview of Possible Beneficial Effects of Black Seeds (Nigella Sativa) on the Management of “Disease X”
Infect. Disord. Drug Targets 25, E18715265304758 (2025); https://doi.org/10.2174/0118715265304758240821113606
/content/journals/iddt/10.2174/0118715265304758240821113606
/content/journals/iddt/10.2174/0118715265304758240821113606
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): black seeds; Disease X; kalonji; Nigella Sativa; pathogen X; thymoquinone

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test